Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (208K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (119)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Simeoni, F.
Right arrow Articles by Divita, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simeoni, F.
Right arrow Articles by Divita, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2003, Vol. 31, No. 11 2717-2724
© 2003 Oxford University Press

Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells

Federica Simeoni, May C. Morris, Frederic Heitz and Gilles Divita

Centre de Recherches de Biochimie Macromoléculaire, Département de Biophysique, FRE-2593 CNRS, 1919 Route de Mende, 34293 Montpellier, France

*To whom correspondence should be addressed at Centre de Recherches en Biochimie Macromoléculaire, Département de Biophysique, UPR-1086 CNRS, 1919 Route de Mende, 34293 Montpellier, France. Tel: +33 04 67 61 33 92; Fax: +33 04 67 52 15 59; Email: divita{at}crbm.cnrs-mop.fr

The improvement of non-viral-based gene delivery systems is of prime importance for the future of gene and antisense therapies. We have previously described a peptide-based gene delivery system, MPG, derived from the fusion peptide domain of HIV-1 gp41 protein and the nuclear localisation sequence (NLS) of SV40 large T antigen. MPG forms stable non-covalent complexes with nucleic acids and improves their delivery. In the present work, we have investigated the mechanism through which MPG promotes gene delivery. We demonstrate that cell entry is independent of the endosomal pathway and that the NLS of MPG is involved in both electrostatic interactions with DNA and nuclear targeting. MPG/DNA particles interact with the nuclear import machinery, however, a mutation which affects the NLS of MPG disrupts these interactions and prevents nuclear delivery of DNA. Nevertheless, we show that this mutation yields a variant of MPG which is a powerful tool for delivery of siRNA into mammalian cells, enabling rapid release of the siRNA into the cytoplasm and promoting robust down-regulation of target mRNA. Taken together, these results support the potential of MPG-like peptides for therapeutic applications and suggest that specific variations in the sequence may yield carriers with distinct targeting features.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
L. Crombez, M. C. Morris, S. Dufort, G. Aldrian-Herrada, Q. Nguyen, G. Mc Master, J.-L. Coll, F. Heitz, and G. Divita
Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth
Nucleic Acids Res., August 1, 2009; 37(14): 4559 - 4569.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
R. Juliano, Md. R. Alam, V. Dixit, and H. Kang
Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides
Nucleic Acids Res., July 1, 2008; 36(12): 4158 - 4171.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
P. Lundberg, S. El-Andaloussi, T. Sutlu, H. Johansson, and U. Langel
Delivery of short interfering RNA using endosomolytic cell-penetrating peptides
FASEB J, September 1, 2007; 21(11): 2664 - 2671.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
D. De Paula, M. V. L.B. Bentley, and R. I. Mahato
Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting
RNA, April 1, 2007; 13(4): 431 - 456.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. C. Morris, E. Gros, G. Aldrian-Herrada, M. Choob, J. Archdeacon, F. Heitz, and G. Divita
A non-covalent peptide-based carrier for in vivo delivery of DNA mimics
Nucleic Acids Res., April 1, 2007; 35(7): e49 - e49.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Veldhoen, S. D. Laufer, A. Trampe, and T. Restle
Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect
Nucleic Acids Res., December 2, 2006; 34(22): 6561 - 6573.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
T. C. Chu, K. Y. Twu, A. D. Ellington, and M. Levy
Aptamer mediated siRNA delivery
Nucleic Acids Res., June 1, 2006; 34(10): e73 - e73.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. A. Wilson and C. D. Richardson
Hepatitis C Virus Replicons Escape RNA Interference Induced by a Short Interfering RNA Directed against the NS5b Coding Region
J. Virol., June 1, 2005; 79(11): 7050 - 7058.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. L. Read, S. Singh, Z. Ahmed, M. Stevenson, S. S. Briggs, D. Oupicky, L. B. Barrett, R. Spice, M. Kendall, M. Berry, et al.
A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids
Nucleic Acids Res., May 24, 2005; 33(9): e86 - e86.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-A. Langlois, C. Boniface, G. Wang, J. Alluin, P. M. Salvaterra, J. Puymirat, J. J. Rossi, and N. S. Lee
Cytoplasmic and Nuclear Retained DMPK mRNAs Are Targets for RNA Interference in Myotonic Dystrophy Cells
J. Biol. Chem., April 29, 2005; 280(17): 16949 - 16954.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Godfrey, J. Anderson, A. Papanastasiou, Y. Takeuchi, and C. Boshoff
Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA
Blood, March 15, 2005; 105(6): 2510 - 2518.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. D. Buckingham, B. Esmaeili, M. Wood, and D. B. Sattelle
RNA interference: from model organisms towards therapy for neural and neuromuscular disorders
Hum. Mol. Genet., October 1, 2004; 13(suppl_2): R275 - R288.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
K. V. Morris, S. W.-L. Chan, S. E. Jacobsen, and D. J. Looney
Small Interfering RNA-Induced Transcriptional Gene Silencing in Human Cells
Science, August 27, 2004; 305(5688): 1289 - 1292.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
Y. Minakuchi, F. Takeshita, N. Kosaka, H. Sasaki, Y. Yamamoto, M. Kouno, K. Honma, S. Nagahara, K. Hanai, A. Sano, et al.
Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo
Nucleic Acids Res., July 22, 2004; 32(13): e109 - e109.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
N. Nitin, P. J. Santangelo, G. Kim, S. Nie, and G. Bao
Peptide-linked molecular beacons for efficient delivery and rapid mRNA detection in living cells
Nucleic Acids Res., April 14, 2004; 32(6): e58 - e58.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.